Brief
Brainsway Completes Nasdaq IPO With $27.5 Million
The Israeli company develops headsets that use magnetic stimulation to treat brain disorders
13:3223.04.19
Israeli medical device company Brainsway Ltd. has completed its initial public offering of its American Depositary Shares on Nasdaq raising its target of $27.5 million, the now dually listed company announced in a filing with the Tel Aviv Stock Exchange Monday. The company began trading on Nasdaq last week.
Brainsway device. Photo: Brainsway
As part of the IPO, Brainsway also provided its underwriters with the option of purchasing up to 375,000 additional shares within 30 days in case of over-allotments.
Founded in 2003, Brainsway develops headsets that use magnetic stimulation to treat brain disorders. Brainsway has offices in Jerusalem and the U.S.
Brainsway device. Photo: Brainsway
